Bristol Myers Squibb (BMY) Debt Ratio (2009 - 2026)

Bristol Myers Squibb has disclosed Debt Ratio across 18 years of filings, most recently posting 0.51 for Q1 2026.

• In Q1 2026, Debt Ratio fell 4.41% year-over-year to 0.51; the TTM figure through Mar 2026 stood at 0.51 (down 4.41% YoY), while the FY2025 annual figure was 0.5, down 6.55% from the prior year.
• Debt Ratio climbed to 0.51 in Q1 2026, from 0.5 in the prior quarter.
• Over the last five years, Debt Ratio for BMY reached as high as 0.56 in Q1 2024 and fell as low as 0.4 in Q3 2022.
• The 5-year median for Debt Ratio is 0.5 (2025), against an average of 0.47.
• Annual changes were most pronounced in 2023 — Debt Ratio declined 8.07% — and 2024, when it soared 40.12%.
• A 5-year view of Debt Ratio shows it stood at 0.41 in 2022, then increased by 2.92% to 0.42 in 2023, then gained by 28.28% to 0.54 in 2024, then dropped by 6.55% to 0.5 in 2025, then climbed by 2.62% to 0.51 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.51, 0.5, and 0.51 for Q1 2026, Q4 2025, and Q3 2025 respectively.